FR2285896A1 - Preparation pharmaceutique destinee a l'administration dans la cavite buccale - Google Patents

Preparation pharmaceutique destinee a l'administration dans la cavite buccale

Info

Publication number
FR2285896A1
FR2285896A1 FR7529278A FR7529278A FR2285896A1 FR 2285896 A1 FR2285896 A1 FR 2285896A1 FR 7529278 A FR7529278 A FR 7529278A FR 7529278 A FR7529278 A FR 7529278A FR 2285896 A1 FR2285896 A1 FR 2285896A1
Authority
FR
France
Prior art keywords
administration
oral cavity
pharmaceutical preparation
preparation intended
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7529278A
Other languages
English (en)
Other versions
FR2285896B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of FR2285896A1 publication Critical patent/FR2285896A1/fr
Application granted granted Critical
Publication of FR2285896B1 publication Critical patent/FR2285896B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7529278A 1974-09-24 1975-09-24 Preparation pharmaceutique destinee a l'administration dans la cavite buccale Granted FR2285896A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49108891A JPS5138412A (en) 1974-09-24 1974-09-24 Kokoseizai no seiho

Publications (2)

Publication Number Publication Date
FR2285896A1 true FR2285896A1 (fr) 1976-04-23
FR2285896B1 FR2285896B1 (fr) 1978-12-01

Family

ID=14496214

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7529278A Granted FR2285896A1 (fr) 1974-09-24 1975-09-24 Preparation pharmaceutique destinee a l'administration dans la cavite buccale

Country Status (5)

Country Link
US (1) US4059686A (fr)
JP (1) JPS5138412A (fr)
DE (1) DE2542158C2 (fr)
FR (1) FR2285896A1 (fr)
GB (1) GB1516359A (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407714A1 (fr) * 1977-11-07 1979-06-01 Toko Yakuhin Kogyo Kk Preparation ophtalmique et son procede de fabrication
FR2415459A1 (fr) * 1978-01-25 1979-08-24 Alcon Lab Inc Preparations locales a usage oculaire
FR2421610A1 (fr) * 1978-04-06 1979-11-02 Vsesojuznyj Kardiologitsches Pellicule medicamenteuse a base d'une substance active a action anti angineuse telle que la nitroglycerine ou l'isosorbide dimitrate
FR2448897A1 (fr) * 1978-06-05 1980-09-12 Riker Laboratories Inc Composition de nitroglycerine, pour application therapeutique directe sur la peau et son procede de preparation
FR2469178A1 (fr) * 1979-11-13 1981-05-22 Nippon Kayaku Kk Solution aqueuse de nitroglycerine et composition pharmaceutique renfermant cette solution
EP0162007A1 (fr) * 1984-04-18 1985-11-21 Geriaco AG Préparation stable et conservable d'insuline pour le traitement de l'acné vulgaris
WO1987004342A1 (fr) * 1986-01-22 1987-07-30 Key Pharmaceuticals, Inc. Composition pour administration buccale
FR2619718A1 (fr) * 1987-09-02 1989-03-03 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
FR2619714A1 (fr) * 1987-09-02 1989-03-03 Medibrevex Nouvelles formes galeniques de theophylline pour administration par voie per- et sublinguale
EP0311540A1 (fr) * 1987-10-08 1989-04-12 Medibrevex Sa Nouvelles formes galéniques de corticoides pour administration par voie per- et sublinguale et leur procédé de préparation
EP0291838A3 (en) * 1987-05-21 1989-05-31 Squibb & Sons Inc Oral drug delivery formulation and method for preparing same
EP0326145A1 (fr) * 1988-01-29 1989-08-02 Konrad Minninger Agent contenant de la sulphadiazine pour thérapie locale externe
EP0355009A1 (fr) * 1988-08-18 1990-02-21 Konrad Minninger Produit pharmaceutique contenant du sulfadiazinat d'argent pour thérapie externe, locale
EP0490891A4 (en) * 1985-05-01 1992-09-16 University Of Utah Research Foundation Drug containing matrix
EP0390541A3 (fr) * 1989-03-31 1992-09-16 Dow Corning Kabushiki Kaisha Base de pâte et sa préparation

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54160752A (en) * 1978-06-12 1979-12-19 Lion Dentifrice Co Ltd Oral composition
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4713239A (en) * 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
US4921695A (en) * 1979-05-29 1990-05-01 Babaian Eduard A Antianginal plate for treating ischemic heart disease
US4842854A (en) * 1979-05-29 1989-06-27 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk Ssr Antianginal plate for treating ischemic heart disease
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
US4311694A (en) * 1979-12-31 1982-01-19 American Cyanamid Company Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials
CA1163195A (fr) * 1980-06-26 1984-03-06 Alec D. Keith Milieu de diffusion polymerique contenant un vasodilatateur
US4329333A (en) * 1980-11-24 1982-05-11 Arthur Barr Method for the oral treatment of dogs and other animals
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US5286748A (en) * 1981-01-05 1994-02-15 Eby Iii George A General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
CA1218604A (fr) * 1981-07-08 1987-03-03 Alec D. Keith Vehicules de trinitroglycerol a decharge temporisee, et leurs domaines d'emploi
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
JPS6013462Y2 (ja) * 1981-08-17 1985-04-30 ライオン株式会社 口腔用バンド
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
US4482533A (en) * 1982-01-11 1984-11-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol
JPS58210007A (ja) * 1982-06-02 1983-12-07 Takeda Chem Ind Ltd 上部「あ」
CA1208558A (fr) * 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
EP0256611A1 (fr) * 1986-08-08 1988-02-24 Squibb Japan Inc. Systèmes d'apport de médicaments oraux
US4975270A (en) * 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients
US4820506A (en) * 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
US5500228A (en) * 1987-05-26 1996-03-19 American Cyanamid Company Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
JP2642354B2 (ja) * 1987-06-11 1997-08-20 株式会社 三和化学研究所 徐放性バッカル剤の製法
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (fr) * 1987-11-24 1995-02-14 James William Mcginity Methode de preparation d'une composition active a liberation prolongee
US5112616A (en) * 1988-11-30 1992-05-12 Schering Corporation Fast dissolving buccal tablet
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
WO1993021905A1 (fr) * 1992-04-23 1993-11-11 Berlex Laboratories, Inc. Emulsion d'huile minerale solide bioadhesive
DK0659073T3 (da) * 1992-09-10 2002-03-11 Childrens Medical Center Bionedbrydelige polymermatrixer med vedvarerende afgivelse af lokalanæstetika
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US6197331B1 (en) 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
DE19819012A1 (de) * 1998-04-29 1999-11-25 Dynamit Nobel Ag Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB0126064D0 (en) * 2001-10-30 2001-12-19 Reckitt Benckiser Healthcare Improvements in or relating to organic compositions
JP2006225398A (ja) * 2002-04-01 2006-08-31 Kaken Pharmaceut Co Ltd 塩基性線維芽細胞増殖因子含有歯科用粘稠製剤
KR100981443B1 (ko) * 2002-04-01 2010-09-13 가켄 세야쿠 가부시키가이샤 염기성 선유 아세포 증식 인자 함유 치과용 점조 제제
US7942669B2 (en) * 2002-12-02 2011-05-17 Centrix, Inc. Gingival tissue retraction device and method
WO2004103303A2 (fr) * 2003-05-16 2004-12-02 Britesmile Development, Inc. Composition dentaire therapeutique
TR200701423T1 (tr) * 2004-09-09 2007-05-21 Bayer Animal Health Gmbh Farmasötik bileşim.
US20060252010A1 (en) * 2005-05-09 2006-11-09 Sunnen Gerard V Sodium chloride pad for treatment of dental conditions
US20080248090A1 (en) * 2005-05-09 2008-10-09 Sunnen Gerard V Graduated concentration sodium chloride patches for the treatment of dental conditions
AU2011236085B2 (en) * 2006-04-05 2014-09-04 Centrix, Inc. Preloaded dental dam and method for gingival tissue retraction
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
KR101474871B1 (ko) * 2006-05-23 2014-12-19 오라헬쓰 코포레이션 아카시아 껌 접착제를 갖는 2층 구강 접착 정제
DK2101740T3 (da) 2006-12-04 2013-11-18 Orexo Ab Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider
DE102008005469A1 (de) * 2008-01-21 2009-07-23 Kettenbach Gmbh & Co. Kg Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung
SMT202100546T1 (it) 2011-09-19 2021-11-12 Orexo Ab Compresse per via sublinguale resistenti all'abuso comprendenti buprenorfina e naloxone
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
CA2911613A1 (fr) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Agoniste de recepteur cgrp pour le traitement ou la prevention du vih

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3029188A (en) * 1958-02-20 1962-04-10 Olin Mathieson Gelatin adhesive pharmaceutical preparations
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
DE2017409C3 (de) * 1970-04-11 1979-11-22 Fa. Heinrich Mack Nachf., 7919 Au Oral anwendbares, cytostatisches Mittel
US3911099A (en) * 1974-01-23 1975-10-07 Defoney Brenman Mayes & Baron Long-acting articles for oral delivery and process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407714A1 (fr) * 1977-11-07 1979-06-01 Toko Yakuhin Kogyo Kk Preparation ophtalmique et son procede de fabrication
FR2415459A1 (fr) * 1978-01-25 1979-08-24 Alcon Lab Inc Preparations locales a usage oculaire
FR2421610A1 (fr) * 1978-04-06 1979-11-02 Vsesojuznyj Kardiologitsches Pellicule medicamenteuse a base d'une substance active a action anti angineuse telle que la nitroglycerine ou l'isosorbide dimitrate
FR2448897A1 (fr) * 1978-06-05 1980-09-12 Riker Laboratories Inc Composition de nitroglycerine, pour application therapeutique directe sur la peau et son procede de preparation
FR2469178A1 (fr) * 1979-11-13 1981-05-22 Nippon Kayaku Kk Solution aqueuse de nitroglycerine et composition pharmaceutique renfermant cette solution
EP0162007A1 (fr) * 1984-04-18 1985-11-21 Geriaco AG Préparation stable et conservable d'insuline pour le traitement de l'acné vulgaris
EP0490891A4 (en) * 1985-05-01 1992-09-16 University Of Utah Research Foundation Drug containing matrix
WO1987004342A1 (fr) * 1986-01-22 1987-07-30 Key Pharmaceuticals, Inc. Composition pour administration buccale
EP0291838A3 (en) * 1987-05-21 1989-05-31 Squibb & Sons Inc Oral drug delivery formulation and method for preparing same
EP0306422A1 (fr) * 1987-09-02 1989-03-08 Medibrevex Sa Nouvelles formes galéniques de béta-2-mimétiques pour administration par voie per- et sublinguale
EP0306423A1 (fr) * 1987-09-02 1989-03-08 Medibrevex Sa Nouvelles formes galéniques de théophylline pour administration par voie per- et sublinguale
FR2619714A1 (fr) * 1987-09-02 1989-03-03 Medibrevex Nouvelles formes galeniques de theophylline pour administration par voie per- et sublinguale
US5080903A (en) * 1987-09-02 1992-01-14 Societe Civile Dite: "Medibrevex" Galenical forms of beta-2-mimetics for administration perlingually and sublingually
FR2619718A1 (fr) * 1987-09-02 1989-03-03 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
EP0311540A1 (fr) * 1987-10-08 1989-04-12 Medibrevex Sa Nouvelles formes galéniques de corticoides pour administration par voie per- et sublinguale et leur procédé de préparation
FR2621483A1 (fr) * 1987-10-08 1989-04-14 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
EP0326145A1 (fr) * 1988-01-29 1989-08-02 Konrad Minninger Agent contenant de la sulphadiazine pour thérapie locale externe
EP0355009A1 (fr) * 1988-08-18 1990-02-21 Konrad Minninger Produit pharmaceutique contenant du sulfadiazinat d'argent pour thérapie externe, locale
WO1990001934A1 (fr) * 1988-08-18 1990-03-08 Konrad Minninger Produit pharmaceutique contenant de la sulfadiazine d'argent pour therapie externe locale
EP0390541A3 (fr) * 1989-03-31 1992-09-16 Dow Corning Kabushiki Kaisha Base de pâte et sa préparation

Also Published As

Publication number Publication date
GB1516359A (en) 1978-07-05
US4059686A (en) 1977-11-22
DE2542158A1 (de) 1976-04-01
FR2285896B1 (fr) 1978-12-01
JPS5138412A (en) 1976-03-31
JPS5438168B2 (fr) 1979-11-19
DE2542158C2 (de) 1985-03-14

Similar Documents

Publication Publication Date Title
FR2285896A1 (fr) Preparation pharmaceutique destinee a l'administration dans la cavite buccale
BE812909A (fr) Perfectionnements a l'obtention de preparations de medicaments a administration par voie orale
BE849632A (fr) Composition pharmaceutique pour l'administration orale
PH13841A (en) Pharmaceutical preparation adapted for oral administration
FR2273555A1 (fr) Agent d'administration intravasculaire
DK143221C (da) Fremgangsmaade til fremstilling af et laegemiddel i folieform til oral eller topisk anvendelse
FR2285895A1 (fr) Supports pour medicaments
RO75336A (fr) Procede pour la preparation d'une forme pharmaceutique destinee a l'administration transdermale du clonidine
ZA751007B (en) Oral pharmaceutical preparation
BE858003A (fr) Compositions pharmaceutiques a base d'alginate de sodium
DK128675A (de) Pharmazeutische zusammensetzung
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
FR2314731A1 (fr) Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
FR2341307A1 (fr) Pyrethrinoides a titre de medicaments et compositions pharmaceutiques les renfermant
BE843140A (fr) Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE832097A (fr) Medicaments en granules friables propres a l'inhalation
BE833394A (fr) Composition pharmaceutique destinee a faciliter l'accouchement
BE802700A (fr) Nouvelles compositions pharmaceutiques a base d'acide glycyrrhetinique
CH524998A (it) Procedimento per l'esecuzione di un modello dentario e mascellare
FR2277577A1 (fr) Derives de l'acide prostanoique et medicaments qui en renferment
FR2283668A1 (fr) Derives de l'acide prostanoique et medicaments qui en contiennent
PH13030A (en) Cephalosporin derivative and pharmaceutical preparation thereof
IL47334A0 (en) Pharmaceutical compositions comprising l-dopa and a synergist and their preparation
DD128671A5 (de) Pharmazeutische mittel
AU5512273A (en) Medicinal preparations for oral use

Legal Events

Date Code Title Description
ST Notification of lapse